Loading…
Ardent Health, Inc. is projected to rise to $13.59 by 2027, a +35% move from its current price of $10.08. ARDT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $9.82 | $10.09 | $10.36 | +0.06% |
| Jul 15 | $9.71 | $10.09 | $10.49 | +0.12% |
| Jul 16 | $9.64 | $10.10 | $10.58 | +0.18% |
| Jul 17 | $9.57 | $10.10 | $10.67 | +0.24% |
| Jul 18 | $9.52 | $10.11 | $10.74 | +0.30% |
| Jul 19 | $9.47 | $10.12 | $10.81 | +0.36% |
| Jul 20 | $9.42 | $10.12 | $10.88 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.42 | $10.12 | $10.88 | +0.43% |
| Week 2 | $9.19 | $10.17 | $11.25 | +0.85% |
| Week 3 | $9.02 | $10.21 | $11.56 | +1.28% |
| Week 4 | $8.88 | $10.25 | $11.83 | +1.71% |
| Week 5 | $8.77 | $10.30 | $12.09 | +2.15% |
| Week 6 | $8.67 | $10.34 | $12.33 | +2.58% |
| Week 7 | $8.59 | $10.38 | $12.55 | +3.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ardent Health, Inc. is a Healthcare company that owns and operates a network of hospitals and clinics in the United States. It provides general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings.
The company also runs ambulatory facilities and telehealth services, comprising primary care and specialty clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. Ardent Health, Inc. operates acute care hospitals, rehabilitation hospitals, and surgical hospitals, forming a broad healthcare network.
It was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee, and it is a subsidiary of EGI-AM Investments, L.L.C.
ARDT trades as a healthcare stock with a current price of $10.13 and a market capitalization of $1.45B, ranking 2297. The current price sits within a near-term framework that is monitored by a range of technical indicators.
The 2026 forecast shows an average price of $10.13 with a neutral sentiment and a range from $7.83 to $14.40, implying no immediate ROI. From 2027 onward, the outlook turns bullish, with the average price rising to $13.53 in 2027 and continuing higher in subsequent years. The long-range forecast envisions substantial upside, culminating in an average price of $94.49 by 2050 and an estimated ROI of 832.7%, signaling a strong bullish trajectory over the multi-decade horizon.
Overall, the asset presents a path of appreciation according to the provided projections, though the near term carries mixed signals and the forecasts are estimates rather than guarantees. The stock remains within a broad, inherently uncertain healthcare equity landscape.
A major floor 34.7% below — a decisive break under it would weaken the trend.
The nearest floor, 22.3% below — buyers have tended to step in here.
The nearest ceiling, 7.3% above — a clean break opens room to run.
A major ceiling 24.7% above — clearing it would confirm fresh momentum.
Key ARDT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARDT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.39 | Sell | $10.22 | Sell |
| MA 10 | $10.23 | Sell | $10.13 | Sell |
| MA 20 | $9.75 | Buy | $9.89 | Buy |
| MA 50 | $9.62 | Buy | $9.64 | Buy |
| MA 100 | $9.45 | Buy | $9.63 | Buy |
| MA 200 | $10.14 | Sell | $10.25 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.86 | Neutral |
| Stoch RSI (14) | 38.02 | Neutral |
| CCI (20) | 44.93 | Neutral |
| Williams %R (14) | -41.34 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 9.80 | Buy |
| Bollinger %B (20,2) | 0.64 | Neutral |
| Stochastic %K (14) | 58.66 | Neutral |
| TRIX (15) | 0.31 | Buy |
| Awesome (5,34) | 0.92 | Buy |
| Ultimate (7,14,28) | 60.54 | Neutral |
| Momentum (10) | 0.72 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 10.23 | Sell |
| ADX (14) | 15.28 | Neutral |
| ATR (14) | 0.23 | Info |
The near-term technical picture is bullish in tone, supported by a bullish overall sentiment. The RSI(14) at 60 suggests relatively positive momentum without being overbought.
The stock’s 50-day simple moving average is $9.54, while the 200-day simple moving average sits at $10.21. Key support is indicated at $7.83 and resistance at $10.13, framing the immediate risk/reward for traders. The 30-day trading range is $8.53 to $12.04, outlining the near-term price volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.83 | $10.08 | $14.21 | 0% | Neutral | |
| $10.83 | $13.59 | $18.04 | +35% | Bullish | |
| $10.67 | $13.77 | $18.96 | +37% | Bullish | |
| $11.75 | $15.52 | $21.99 | +54% | Bullish | |
| $12.68 | $17.08 | $24.80 | +69% | Bullish | |
| $13.25 | $18.18 | $26.96 | +80% | Bullish | |
| $16.93 | $23.64 | $35.72 | +134% | Bullish | |
| $18.53 | $26.29 | $40.41 | +161% | Bullish | |
| $19.21 | $27.67 | $43.22 | +175% | Bullish | |
| $21.06 | $30.78 | $48.79 | +205% | Bullish | |
| $30.14 | $47.08 | $79.35 | +367% | Bullish | |
| $52.22 | $91.44 | $168.55 | +807% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.83 | $10.08 | $11.97 | +0.00% |
| August 2026 | $8.79 | $10.37 | $12.56 | +2.89% |
| September 2026 | $8.97 | $10.65 | $13.05 | +2.72% |
| October 2026 | $8.87 | $10.60 | $13.10 | -0.51% |
| November 2026 | $8.99 | $10.80 | $13.45 | +1.88% |
| December 2026 | $9.38 | $11.32 | $14.21 | +4.86% |
Click any year to see its month-by-month ARDT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ARDT to range from $7.83 to $14.21 through 2026. The $10.08 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ARDT price prediction for 2027 points to an average of $13.59 (low $10.83, high $18.04) — a potential gain of +35% on today's $10.08. Buyers look set to stay in control over this stretch.
In 2028, ARDT is projected to trade between $10.67 and $18.96, averaging $13.77 — a potential gain of +37% from today's $10.08. That is up +1% on the projected 2027 average. Momentum favours further upside here.
Ardent Health, Inc.'s 2029 outlook centres on $15.52, within a $11.75 to $21.99 range. That is up +13% on the projected 2028 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ARDT could reach as high as $24.80, with a base case around $17.08 and support toward $12.68 — roughly +69% from $10.08. Momentum favours further upside here.
Expect ARDT to range from $13.25 to $26.96 through 2031. The $18.18 average target implies a +80% move from current prices. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ARDT price prediction for 2032 points to an average of $23.64 (low $16.93, high $35.72) — a potential gain of +134% on today's $10.08. Momentum favours further upside here.
In 2033, ARDT is projected to trade between $18.53 and $40.41, averaging $26.29 — a potential gain of +161% from today's $10.08. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Ardent Health, Inc.'s 2034 outlook centres on $27.67, within a $19.21 to $43.22 range. That is up +5% on the projected 2033 average. That marks a +175% change versus current levels. Momentum favours further upside here.
By 2035, ARDT could reach as high as $48.79, with a base case around $30.78 and support toward $21.06 — roughly +205% from $10.08. Buyers look set to stay in control over this stretch.
Expect ARDT to range from $30.14 to $79.35 through 2040. The $47.08 average target implies a +367% move from current prices. That is up +53% on the projected 2035 average. Momentum favours further upside here.
The ARDT price prediction for 2050 points to an average of $91.44 (low $52.22, high $168.55) — a potential gain of +807% on today's $10.08. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARDT today (≈ 99.206349 ARDT) could be worth
$9,071.85
+$8,071.85 (+807%) by 2050 · US Dollar
Based on the average projected ARDT price of $91.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARDTwould be worth at today's price.
$1,000 invested in ARDT on Jul 10, 2025 (≈ 70.077083 ARDT) would be worth
$706.38
-$293.62 (-29.4%) today · 0.71× · US Dollar
Based on a ARDT entry price of $14.27 vs. today's $10.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.76 | $936.8 | -6.3% |
| 1 month ago | $9.32 | $1,081.55 | +8.2% |
| 3 months ago | $9.4 | $1,072.34 | +7.2% |
| 6 months ago | $8.86 | $1,137.7 | +13.8% |
| 1 year ago | $14.27 | $706.38 | -29.4% |
| All time (2.0y) ago | $16.06 | $627.65 | -37.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARDT forecast.
Our base-case forecast reaches $20.00 around 2032.
Implied market cap at $20.00: $2.87B
In the multi-year forecast, the average price is projected to rise from $10.13 in 2026 to $17.27 by 2030, signaling a strong upward trajectory supported by a bullish sentiment from 2027 onward. The 2030 average of $17.27 carries an estimated ROI of 70.5% and reflects continued upside potential.
Looking further out, the 2040 average is $48.38 with a 377.6% ROI, and the 2050 average is $94.49 with an 832.7% ROI, both indicating substantial long-term upside and a sustained bullish stance. The forecast also shows higher annual averages in intermediate years (for example 2027 $13.53, 2028 $14.05, 2029 $15.79), underscoring a progressive appreciation path.
These projections are estimates and not guarantees; they presume the continuation of favorable conditions and do not account for unforeseen risks. Investors should consider the near-term uncertainty and the long-term upside potential when evaluating the asset.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $17.27, with a minimum of $12.89 and a maximum of $24.91, and an estimated ROI of 70.5% with bullish sentiment.
The outlook shows bullish sentiment in the years beyond 2026, with the average price rising to $17.27 by 2030 and to $94.49 by 2050, corresponding to higher potential returns (832.7% ROI by 2050). These figures are estimates, not guarantees, and should be weighed with risk considerations.
Yes. The forecast maximum reaches $80.67 by 2040 and $171.93 by 2050, while the 2040 average is $48.38, suggesting that reaching or exceeding $50 is within the projected pathway under favorable conditions.
The current price is $10.13 and the market cap is $1.45B, with a rank of 2297.
The near-term picture shows bullish sentiment with RSI(14) at 60. The SMA50 is $9.54 and the SMA200 is $10.21, with support at $7.83 and resistance at $10.13; the 30-day range is $8.53 to $12.04.
Ardent Health, Inc. Community Discussion
0Share your Ardent Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.